Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Stage HCC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Not applicableUnknownNCT01470495
What this trial is testing

Combined Treatment of RFA and Sorafenib on Recurrent HCC

Who this might be right for
HCCRadiofrequency AblationSorafenib
Southwest Hospital, China 430
Not applicableUnknownNCT02046356
What this trial is testing

Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation

Who this might be right for
Hepatocellular Carcinoma
Yunhua Tan 139
Not applicableNot Yet RecruitingNCT07582419
What this trial is testing

Hybrid Deep Learning Integrating Multimodal CEUS and Enhanced MRI to Optimize Early-Stage HCC Treatment Decisions

Who this might be right for
Hepatocellular Carcinoma (HCC)
The First Hospital of Jilin University 1,424
Large-scale testing (Phase 3)UnknownNCT02169765
What this trial is testing

HR Versus RFA for Early Stage HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Guangxi Medical University 120
Large-scale testing (Phase 3)Looking for participantsNCT06841172
What this trial is testing

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

Who this might be right for
OligoProgressive Metastatic DiseaseHepatocellular Carcinoma (HCC)Radiotherapy+1 more
Shandong Cancer Hospital and Institute 132
Not applicableEnded earlyNCT02704130
What this trial is testing

TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatomaLiver Cancer, Adult+2 more
Wake Forest University Health Sciences 8
Not applicableStudy completedNCT02728193
What this trial is testing

Standard Treatments of Very-early Stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaVery-early Stage
Eastern Hepatobiliary Surgery Hospital 300
Post-approval studies (Phase 4)WithdrawnNCT02959359
What this trial is testing

DAA in the Risk of Recurrence After Curative Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan
Early research (Phase 1)Looking for participantsNCT07391670
What this trial is testing

A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab

Who this might be right for
Solid Tumours
AstraZeneca 40
Not applicableEnded earlyNCT05451862
What this trial is testing

Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular Carcinoma
Terumo Europe N.V. 6
Not applicableStudy completedNCT06776185
What this trial is testing

Recurrence Patterns and Cost-Effectiveness of Surgical Approaches in Early-Stage Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Chen Xiaoping 3,000
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Not applicableEnded earlyNCT04235660
What this trial is testing

Y90 Radiation Segmentectomy vs SBRT for HCC

Who this might be right for
Hepatocellular Carcinoma (HCC)
Indiana University 2
Not applicableStudy completedNCT07030842
What this trial is testing

Precision Recurrence Risk Assessment in Early-stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tongji Hospital 579
Testing effectiveness (Phase 2)Study completedNCT03203005
What this trial is testing

IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute, Naples 22
Not applicableUnknownNCT02187081
What this trial is testing

Radiofrequency Ablation Accompanied With Spontaneous Sorafenib in Early to Intermediate Stage HCC

Who this might be right for
HCC
Southwest Hospital, China 380
Not applicableStudy completedNCT02774161
What this trial is testing

B-mode Ultrasound Imaging in Detecting Early Liver Cancer

Who this might be right for
CirrhosisEarly Hepatocellular CarcinomaFibrosis+2 more
Stanford University 45
Early research (Phase 1)Active Not RecruitingNCT06218511
What this trial is testing

A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)

Who this might be right for
Hepatocellular Carcinoma
National Cancer Institute, Naples 10
Not applicableUnknownNCT02525965
What this trial is testing

The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 194